Earnings Feed
Start Free
Home/Filings/4/0001232524-12-000013
4//SEC Filing

Gamble Carol A 4

Accession 0001232524-12-000013

CIK 0001232524other
View on SEC.govCompany Profile

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 5:55 PM ET

Size

46.7 KB

Accession

0001232524-12-000013

Insider Transaction Report

Form 4
Period: 2012-01-11
JAZZ PHARMACEUTICALS INCJAZZ
Gamble Carol A
SVP, GC and Secretary
Transactions
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−12,797$621,934→ 31,605 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$7.96/sh+25,133$200,059→ 61,420 total
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−13,879$674,519→ 63,896 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$15.09/sh+48,114$726,040→ 58,788 total
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−30,425$1,478,655→ 28,363 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$45.27/sh+16,039$726,086→ 47,644 total
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−6,916$336,118→ 36,287 total
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−12,531$609,007→ 48,889 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$1.25/sh+28,886$36,108→ 77,775 total
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−28,886→ 2,229 total
    Exercise: $1.25Exp: 2019-01-20→ Common Stock (28,886 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−25,039→ 14,961 total
    Exercise: $11.48Exp: 2020-03-07→ Common Stock (25,039 underlying)
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−15,452$750,967→ 32,192 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$11.48/sh+25,039$287,448→ 88,935 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$27.46/sh+35,000$961,100→ 109,094 total
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−16,039→ 4,845 total
    Exercise: $30.18Exp: 2014-02-17→ Common Stock (16,039 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−11,011→ 11,579 total
    Exercise: $19.37Exp: 2017-02-26→ Common Stock (11,011 underlying)
  • Exercise/Conversion

    Common Stock

    2012-01-11$30.18/sh+16,039$484,057→ 44,402 total
  • Exercise/Conversion

    Common Stock

    2012-01-11$19.37/sh+11,011$213,283→ 43,203 total
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−48,114→ 14,538 total
    Exercise: $15.09Exp: 2014-02-17→ Common Stock (48,114 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−25,133→ 3,752 total
    Exercise: $7.96Exp: 2018-05-15→ Common Stock (25,133 underlying)
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−14,841$721,273→ 74,094 total
  • Tax Payment

    Common Stock

    2012-01-11$48.60/sh−26,881$1,306,417→ 82,213 total
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−16,039→ 4,845 total
    Exercise: $45.27Exp: 2014-02-17→ Common Stock (16,039 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2012-01-11−35,000→ 0 total
    Exercise: $27.46Exp: 2021-03-09→ Common Stock (35,000 underlying)
Footnotes (9)
  • [F1]Represents shares withheld by the Issuer for cashless exercise of nonstatutory stock options solely to cover exercise price and required withholding taxes.
  • [F2]This option, consisting of a nonstatutory stock option exercisable for 48,114 shares of common stock and an incentive stock option exercisable for 14,538 shares of common stock, vested one fourth on February 18, 2005, one eighth on August 18, 2005, and the remainder in 30 equal monthly installments thereafter.
  • [F3]This option, consisting of a nonstatutory stock option exercisable for 16,039 shares of common stock and an incentive stock option exercisable for 4,845 shares of common stock, vested one fourth on February 18, 2005, one eighth on August 18, 2005, and the remainder in 30 equal monthly installments thereafter.
  • [F4]This option, consisting of a nonstatutory stock option exercisable for 11,011 shares of common stock and an incentive stock option exercisable for 11,579 shares of common stock, has a vesting schedule of one third vested on February 27, 2010 and the remainder vesting in 24 equal monthly installments thereafter.
  • [F5]This option, consisting of a nonstatutory stock option exercisable for 25,133 shares of common stock and an incentive stock option exercisable for 3,752 shares of common stock, has a vesting schedule of one half vested on April 8, 2010 and the remainder vesting in 24 equal monthly installments thereafter.
  • [F6]This option, consisting of a nonstatutory stock option exercisable for 28,886 shares of common stock and an incentive stock option exercisable for 2,229 shares of common stock, has a vesting schedule of one third vested on January 21, 2010 and the remainder vesting in 24 equal monthly installments thereafter.
  • [F7]This option, consisting of a nonstatutory stock option exercisable for 25,039 shares of common stock and an incentive stock option exercisable for 14,961 shares of common stock, has a vesting schedule of one fourth vested on March 8, 2011 and the remainder vesting in 36 equal monthly installments thereafter.
  • [F8]This nonstatutory stock option has a vesting schedule of one fourth vesting on March 1, 2012 and the remainder vesting in 36 equal monthly installments thereafter.
  • [F9]On October 24, 2011, the Board of Directors of the Issuer approved the full vesting of unvested nonstatutory stock options held by the Issuer's officers and non-employee directors, including the Reporting Person. Such vesting acceleration became effective on December 13, 2011.

Documents

1 file

Issuer

JAZZ PHARMACEUTICALS INC

CIK 0001232524

→
Entity typeother

Related Parties

1
  • filerCIK 0001397267

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:55 PM ET
Size
46.7 KB
View on SEC.gov